Introduction

Recent research conducted in Norway provides insightful data on the epidemiology of classic psychedelic substances, including psilocybin and lysergic acid diethylamide (LSD), focusing on their use, risks, and benefits. This study, outlined in the paper "Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample" by Kvam et al. (2023), offers valuable perspectives for organizations dedicated to psychedelic harm reduction and public education on the responsible use of these substances.

Methodology

The study recruited 841 participants, focusing on adults in Norway who have had a memorable experience with classic psychedelics. It employed an extensive internet survey covering aspects related to recreational and therapeutic use.

Findings

A significant finding is that the majority of participants engaged with psychedelics primarily for recreational (46.1%) or therapeutic (42.3%) purposes, with psilocybin being the most common substance for these memorable experiences. Preparation before use, processing during, and integration after the psychedelic experience were common among participants, mimicking protocols observed in clinical trials. However, only a minority had the support of a therapist during their experience.

Discussion

This self-administered approach to psychedelics underlines the importance of harm reduction practices, as it involves significant self-perceived improvements in symptoms of mental and substance use disorders among users. Yet, it also brings to light the risks associated with unsupervised use. Although adverse reactions were generally mild and transient, 4.2% of participants reported long-lasting adverse effects, and 2.9% experienced persisting flashbacks for a year or more.

Conclusion

In conclusion, while classic psychedelics can lead to self-reported improvements in mental health and substance use disorders, a small but significant portion of users experience persistent adverse effects. This underscores the critical need for harm reduction strategies, including education on safe use practices, the potential benefits of therapeutic guidance, and the importance of post-experience integration. For the harm reduction community, these findings reinforce the mission to provide comprehensive support and education, ensuring that those who choose to use psychedelics do so with the utmost safety and awareness of the potential risks and benefits (Kvam et al., 2023).